| Literature DB >> 30567843 |
Agnieszka A Wendorff1, S Aidan Quinn1,2, Marissa Rashkovan1, Chioma J Madubata3, Alberto Ambesi-Impiombato1, Mark R Litzow4, Martin S Tallman5, Elisabeth Paietta6, Maddalena Paganin7, Giuseppe Basso7,8, Julie M Gastier-Foster9,10,11,12, Mignon L Loh13,14, Raul Rabadan3,15, Pieter Van Vlierberghe16,17, Adolfo A Ferrando18,2,3,19.
Abstract
The plant homeodomain 6 gene (PHF6) is frequently mutated in human T-cell acute lymphoblastic leukemia (T-ALL); however, its specific functional role in leukemia development remains to be established. Here, we show that loss of PHF6 is an early mutational event in leukemia transformation. Mechanistically, genetic inactivation of Phf6 in the hematopoietic system enhances hematopoietic stem cell (HSC) long-term self-renewal and hematopoietic recovery after chemotherapy by rendering Phf6 knockout HSCs more quiescent and less prone to stress-induced activation. Consistent with a leukemia-initiating tumor suppressor role, inactivation of Phf6 in hematopoietic progenitors lowers the threshold for the development of NOTCH1-induced T-ALL. Moreover, loss of Phf6 in leukemia lymphoblasts activates a leukemia stem cell transcriptional program and drives enhanced T-ALL leukemia-initiating cell activity. These results implicate Phf6 in the control of HSC homeostasis and long-term self-renewal and support a role for PHF6 loss as a driver of leukemia-initiating cell activity in T-ALL. SIGNIFICANCE: Phf6 controls HSC homeostasis, leukemia initiation, and T-ALL leukemia-initiating cell self-renewal. These results substantiate a role for PHF6 mutations as early events and drivers of leukemia stem cell activity in the pathogenesis of T-ALL.This article is highlighted in the In This Issue feature, p. 305. ©2018 American Association for Cancer Research.Entities:
Year: 2018 PMID: 30567843 PMCID: PMC6425751 DOI: 10.1158/2159-8290.CD-18-1005
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397